Deutsche Bank Maintains Sell on AstraZeneca (AZN)

AstraZeneca PLC (NYSE:AZN) is one of the 10 Top Stocks Fund Managers Are Loading Up On in 2026.

Deutsche Bank Maintains Sell on AstraZeneca (AZN)

On March 27, 2026, Deutsche Bank maintained a Sell rating on AstraZeneca PLC (NYSE:AZN). The firm’s analyst kept a price target of £115 on the stock. On the other hand, in a more recent update, Guggenheim raised the firm’s price target on AstraZeneca PLC (NYSE:AZN) from 16,000 GBp to 16,500 GBp. Analyst Seamus Fernandez kept a Buy rating on the company’s stock. The firm made the adjustment following an update of its financial model ahead of Q1 earnings.

In another development, on March 31, 2026, AstraZeneca PLC (NYSE:AZN) announced positive Phase III results for efzimfotase alfa – an investigational enzyme replacement therapy for hypophosphatasia. The program covered 196 patients across 22 countries to provide a lower-volume, less frequent dosing alternative to Strensiq. The MULBERRY trial met all primary endpoints in treatment-naive pediatric patients, showing significant bone health improvements. In addition, the CHESTNUT study confirmed that children who switched from Strensiq maintained clinical benefits. The HICKORY trial missed its primary mobility endpoint in adults but showed meaningful functional gains in pediatric-onset subgroups.

Founded in 1999 through the merger of Astra AB and Zeneca Group, AstraZeneca PLC (NYSE:AZN) is a global biopharmaceutical leader with headquarters in the United Kingdom. The company focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

While we acknowledge the risk and potential of AZN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than AZN and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 11 Best Stocks You’ll Wish You Bought Sooner and 15 Set-It-and-Forget-It Stocks to Buy in 2026

Disclosure: None.  Follow Insider Monkey on Google News.